ID

15781

Description

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01689662

Link

https://clinicaltrials.gov/show/NCT01689662

Keywords

Versions (1)
  1. 6/13/16 6/13/16 -
Uploaded on

June 13, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Metastatic Renal Cell Carcinoma NCT01689662

English

Eligibility Metastatic Renal Cell Carcinoma NCT01689662

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. subject must be 18 years of age or older.
Description

subjects must meet the following eligibility requirements to be enrolled in the study.

Data type

boolean

Alias
UMLS CUI [1]
C0001779
2. subject must have known or strongly suspected metastatic renal cell carcinoma with at least one target lesion as identified by ultrasonography, mri, or ct.
Description

metastatic renal cell carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C0278678
3. subject must have good kidney function.
Description

kidney function

Data type

boolean

Alias
UMLS CUI [1]
C0232804
4. subject must provide written informed consent prior to enrollment.
Description

written informed

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. subject is pregnant or breastfeeding.
Description

subjects must be excluded if any of the following conditions are present:

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
2. subject is simultaneously participating in another investigational drug study, excluding the follow-up phase.
Description

participating in another study

Data type

boolean

Alias
UMLS CUI [1]
C2348568
3. subject has received an investigational agent within 7 days prior to enrollment.
Description

investigational agent

Data type

boolean

Alias
UMLS CUI [1]
C1875319
4. subject is unable to tolerate conditions for radionuclide imaging.
Description

radionuclide imaging

Data type

boolean

Alias
UMLS CUI [1]
C0034606
5. subject has been administered another radiopharmaceutical that would interfere with the assessment of technetium tc 99m ec20.
Description

technetium tc 99m ec20

Data type

boolean

Alias
UMLS CUI [1,1]
C0182638
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C1883272
Back to the top of the page

Similar models

Eligibility Metastatic Renal Cell Carcinoma NCT01689662

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
1. subject must be 18 years of age or older.
boolean
C0001779 (UMLS CUI [1])
metastatic renal cell carcinoma
Item
2. subject must have known or strongly suspected metastatic renal cell carcinoma with at least one target lesion as identified by ultrasonography, mri, or ct.
boolean
C0278678 (UMLS CUI [1])
kidney function
Item
3. subject must have good kidney function.
boolean
C0232804 (UMLS CUI [1])
written informed
Item
4. subject must provide written informed consent prior to enrollment.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
pregnancy or breast-feeding
Item
1. subject is pregnant or breastfeeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
participating in another study
Item
2. subject is simultaneously participating in another investigational drug study, excluding the follow-up phase.
boolean
C2348568 (UMLS CUI [1])
investigational agent
Item
3. subject has received an investigational agent within 7 days prior to enrollment.
boolean
C1875319 (UMLS CUI [1])
radionuclide imaging
Item
4. subject is unable to tolerate conditions for radionuclide imaging.
boolean
C0034606 (UMLS CUI [1])
technetium tc 99m ec20
Item
5. subject has been administered another radiopharmaceutical that would interfere with the assessment of technetium tc 99m ec20.
boolean
C0182638 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C1883272 (UMLS CUI [1,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial